NCT07939854
Stereotactic Aspiration Combined With Tenecteplase for Acute Pontine Hemorrhage
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Proportion of Participants With GCS Score >8
Timeframe: 90 days after randomization
All-Cause Mortality
Timeframe: Within 30 days after randomization.
Secondary (9)
7-Day All-Cause Mortality
Symptomatic Rebleeding
Intracranial Bacterial Infection
Serious Adverse Events (SAEs)
Adverse Events (AEs)
Show 4 moreShow less
Proportion With GCS Increase ≥3 Points
Proportion With Recovery of Consciousness
Proportion With mRS 0-3
Change in GCS Score Over Time
Arms and interventions
Stereotactic Aspiration Combined With TenecteplaseExperimental
Participants will receive neuronavigation-guided stereotactic hematoma aspiration followed by intralesional tenecteplase administration, in addition to standard medical treatment.
Standard Medical TreatmentActive comparator
Procedures: Neuronavigation-Guided Stereotactic Hematoma Aspiration
Drugs: Tenecteplase
Other: Standard Medical Treatment
Sites
1 site in 1 country
- Beijing Tiantan Hospital, Capital Medical UniversityBeijing, Beijing Municipality, China